West completed the sale and transfer of SmartDose 3.5mL rights
The transaction closed on July 1, 2026. West retains other SmartDose versions.
See the latest news and media coverage for West. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of injectable drug packaging and delivery systems
westpharma.comLast updated
In short: West grew Q1 2026 sales by 21%, appointed Michel Lagarde as the new CEO, and expanded its Dublin facility to meet injectable drug demand.
The transaction closed on July 1, 2026. West retains other SmartDose versions.
The report details progress on renewable energy projects and SBTi-validated climate goals, emphasizing People, Process, and Planet pillars.
He will succeed Eric M. Green, who is retiring, and Robert F. Friel becomes Board Chair.
The revised Annex 1 reshapes sterile manufacturing, with CCS becoming a strategic differentiator and suppliers as quality partners.
West Pharmaceutical Services WST recently completed the sale and transfer of the manufacturing and...
West Pharmaceutical Services Inc has an Investment Rating of BUY; a target price of $392.000000; an Industry Subrating of Medium; a Management Subrating of High...
West Pharmaceutical Services stock hits 52-week high at 363.38 USD...
EXTON, Pa., July 1, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced...
Track West and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to West and other trending companies.